TCTR20200128004已完成2 期
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover study
ampang hospital0 个研究点目标入组 10 人开始时间: 2020年1月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •ESRD patients (defined by Kidney Disease Initiative Global Outcome (KDIGO)
- •Guideline 2012) requiring chronic hemodialysis
- •- Hemodialysis vintage more than 3 months
- •- Hemodialysis with 2 sessions per week
- •- History of intradialytic hypotension at least 30% of their dialysis sessions during the
- •past 3 months
排除标准
- •- Active cardiac, pulmonary or hepatobiliary tract disease
- •- Active infection or sepsis
- •- Systemic fungal infection
- •- Require ultrafiltration more than 4L per session
- •- Active malignancy
- •- Prior treatment with fludocortisone in past 4 weeks
- •- Contraindication to fludocortisone
研究者
相似试验
已完成
不适用
Effect of spironolactone on ischemia reperfusion injury in renal transplant recipientsIschemia reperfusion injuryCirculatory SystemISRCTN01577227Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)60
已完成
2 期
Effects of mineralocorticoid receptor antagonist on intradialytic hypertension: a multicenter, double-blind, randomized crossover studyIntradialytic hypertensionSpironolactoneMineralocorticoid receptor antagonistTCTR20200604013ampang hospital49
已完成
不适用
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertensiodrug-resistant morning hypertensionJPRN-UMIN000014186Jichi Medical University School of Medicine100
已完成
不适用
Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000037657Tokyo Women's Medical University Hospital100
进行中（未招募）
1 期
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors?depressed patients and healthy control subjectsEUCTR2014-005239-15-DECharité - Universitätsmedizin Berlin232